Adapt Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADAPT, and what generic and branded alternatives to ADAPT drugs are available?
ADAPT has twenty-one approved drugs.
Summary for Adapt
US Patents: | 0 |
Tradenames: | 19 |
Ingredients: | 19 |
NDAs: | 21 |
Patent Litigation for Adapt: | See patent lawsuits for Adapt |
Drugs and US Patents for Adapt
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-003 | Jul 18, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 208113-004 | May 17, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Adaptis | ACYCLOVIR | acyclovir | CAPSULE;ORAL | 075090-001 | Jan 26, 1999 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-006 | Jul 18, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Adaptis | PREGABALIN | pregabalin | CAPSULE;ORAL | 216197-002 | Jul 18, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Adaptis | IBUPROFEN | ibuprofen | TABLET;ORAL | 071265-002 | Sep 10, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Adaptis | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 214308-001 | May 22, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ADAPT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Nasal Spray | 4 mg/spray | ➤ Subscribe | 2016-07-15 |